Robert Barron
About Robert Barron
Robert Barron serves as a Senior FP&A Analyst at Hinge Health, where he has worked since 2019. He has a background in financial analysis and research, with previous roles at Intrexon Corporation and Quid, and holds a Bachelor's Degree in Biology and Economics from Bowdoin College.
Work at Hinge Health
Robert Barron has served as a Senior FP&A Analyst at Hinge Health since 2019. In this role, he has contributed to financial planning and analysis efforts, focusing on strategic initiatives within the organization. His responsibilities include scrutinizing proof-of-concept proposals to establish business cases, which aids in the decision-making process for new projects. Barron operates from the company's San Francisco office, where he collaborates with various teams to enhance financial performance and operational efficiency.
Previous Experience in Financial Analysis
Before joining Hinge Health, Robert Barron worked at Quid as an Associate in Enterprise Services focused on Healthcare from 2017 to 2019. His role involved analyzing market trends and providing insights to support business strategies. Additionally, he briefly worked at Intrexon Corporation as a Financial Research Analyst in the Biological Engineering Group, where he engaged in mergers and acquisitions for two months in 2016. His earlier experience also includes a position as a Research Scientist at Bowdoin College, where he contributed to scientific research from 2015 to 2017.
Education and Expertise
Robert Barron earned a Bachelor’s Degree in Biology and Economics from Bowdoin College, where he studied from 2013 to 2017. His academic background provides a strong foundation in both scientific and economic principles, which he applies in his financial analysis work. Barron's education has equipped him with the analytical skills necessary to evaluate market research and strategic planning initiatives effectively.
Key Contributions in Financial Research
During his tenure at Intrexon Corporation, Robert Barron identified and valued five live acquisition targets within the pharmaceutical and biotech sectors. He utilized discounted cash flow and comparable transaction modeling techniques to assess these targets. His analytical skills have been instrumental in reviewing market research and strategic planning initiatives, contributing to informed decision-making processes in the organizations he has worked for.